Blink AG

Jena, TH

UEI
K3HNLHGUQBW4
CAGE
CN9B4
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Brüsseler Str. 20, 07747 Jena, Germany
Website
blink-dx.com
Founded
2015
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Rutgers The State University Of New Jersey Nanoreactor beads for POC TB resistance testing R01AI179961 $216,000
Rutgers The State University Of New Jersey Nanoreactor beads for POC TB resistance testing R01AI179961 $21,600
Rutgers The State University Of New Jersey Nanoreactor beads for POC TB resistance testing R01AI179961 $194,000

Similar vendors

About the company

Blink AG is a foreign-owned, for-profit corporate entity based in Jena, Germany, with a registered presence in the U.S. federal government's System for Award Management (SAM.gov) through February 2026. The company appears to be a manufacturer of specialized scientific or medical goods, focusing on advanced materials and nanotechnology development. While primarily operating as a foreign corporate entity, Blink AG has established connections with U.S. academic research institutions, particularly in scientific research and development contexts.

The company's federal grant activities are exclusively centered on sub-award grants through Rutgers University, specifically related to nanoreactor bead technology for point-of-care (POC) tuberculosis resistance testing. Blink AG has received three consecutive sub-grant awards from Rutgers, dated February 13, 2024, September 7, 2024, and January 31, 2025, all supporting the same research initiative involving nanoreactor beads designed for tuberculosis diagnostic testing. These grants suggest Blink AG provides specialized nanomaterials or nanotechnology components that support advanced medical diagnostic research, likely in collaboration with biomedical researchers at Rutgers University. The consistent repetition of sub-awards indicates an ongoing research partnership focused on developing innovative diagnostic technologies for tuberculosis resistance testing.

Quick answers

Is Blink AG registered in SAM.gov?

Yes. Blink AG's SAM.gov registration is active through February 25, 2027.

On GovTribe

See Blink AG's full federal record

  • Similar vendors